Point72 Asset Management L.P. raised its holdings in shares of Morphic Holding, Inc. (NASDAQ:MORF – Free Report) by 83.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,591,000 shares of the company’s stock after purchasing an additional 2,086,617 shares during the quarter. […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Get Free Report) insider Thomas Gad sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $12.03, for a total transaction of $421,050.00. Following the completion of the sale, the insider now directly owns 197,681 […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares rose 8.8% during trading on Wednesday . The stock traded as high as $23.51 and last traded at $23.44. Approximately 139,605 shares were traded during trading, a decline of 42% from the average daily volume of 241,645 shares. The stock had previously closed at $21.55. Analyst […]
Artia Global Partners LP purchased a new stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 19,638 shares of the company’s stock, valued at approximately $488,000. RAPT Therapeutics accounts for approximately 0.1% of […]
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) COO Anish Patel sold 1,133 shares of Enliven Therapeutics stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $20.06, for a total transaction of $22,727.98. The transaction was disclosed in a legal filing with the SEC, which […]